National Tuberculosis Advisory Committee Guideline: Management of Tuberculosis Risk in Healthcare Workers in Australia.

IF 1.6 Q4 INFECTIOUS DISEASES Communicable Diseases Intelligence Pub Date : 2017-09-01
Justin Waring, Justin Waring
{"title":"National Tuberculosis Advisory Committee Guideline: Management of Tuberculosis Risk in Healthcare Workers in Australia.","authors":"Justin Waring,&nbsp;Justin Waring","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Tuberculosis (TB) is uncommon in Australia and not commonly managed by most healthcare workers (HCWs). However, even in a low incidence setting, occasional exposure of HCWs is inevitable and transmission of TB to HCWs leading to disease does occur. In addition, HCWs may have been recruited to Australia from countries with high TB incidence. These HCWs are more likely to be infected with TB before arrival and subsequently develop active disease while working in health settings in Australia. In 2001, there were 20 TB notifications in HCWs in Australia, of which 10 were born overseas, whereas in 2013, 70 of 77 notified cases (91%) were people born overseas.1, 2 Managing the risk of TB in HCWs is multifaceted. A combination of staff education, awareness, early diagnosis, appropriate use of personal protective equipment (PPE), environmental controls and screening procedures is required to minimise the risk of transmission to HCWs and from HCWs to patients. Prevention of nosocomial transmission from HCWs is particularly important in patients that are more vulnerable, for example children and the immunocompromised. This document aims to describe the components that are considered essential for all healthcare facilities in Australia to minimise this risk. It is not intended to be operational, and reference should be made to specific state and territory TB Control Program policies for this detail. Each facility should develop its own policy for the management of TB risk in HCWs according to this jurisdictional policy and the facility specific factors that determine risk, but it should include at least the following components.</p>","PeriodicalId":51669,"journal":{"name":"Communicable Diseases Intelligence","volume":"41 3","pages":"E199-E203"},"PeriodicalIF":1.6000,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Communicable Diseases Intelligence","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Tuberculosis (TB) is uncommon in Australia and not commonly managed by most healthcare workers (HCWs). However, even in a low incidence setting, occasional exposure of HCWs is inevitable and transmission of TB to HCWs leading to disease does occur. In addition, HCWs may have been recruited to Australia from countries with high TB incidence. These HCWs are more likely to be infected with TB before arrival and subsequently develop active disease while working in health settings in Australia. In 2001, there were 20 TB notifications in HCWs in Australia, of which 10 were born overseas, whereas in 2013, 70 of 77 notified cases (91%) were people born overseas.1, 2 Managing the risk of TB in HCWs is multifaceted. A combination of staff education, awareness, early diagnosis, appropriate use of personal protective equipment (PPE), environmental controls and screening procedures is required to minimise the risk of transmission to HCWs and from HCWs to patients. Prevention of nosocomial transmission from HCWs is particularly important in patients that are more vulnerable, for example children and the immunocompromised. This document aims to describe the components that are considered essential for all healthcare facilities in Australia to minimise this risk. It is not intended to be operational, and reference should be made to specific state and territory TB Control Program policies for this detail. Each facility should develop its own policy for the management of TB risk in HCWs according to this jurisdictional policy and the facility specific factors that determine risk, but it should include at least the following components.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
国家结核病咨询委员会指南:澳大利亚卫生保健工作者结核病风险管理。
结核病(TB)在澳大利亚并不常见,大多数卫生保健工作者(HCWs)通常不进行管理。然而,即使在低发病率的环境中,偶尔接触卫生工作者也是不可避免的,并且确实发生了将结核病传播给卫生工作者导致疾病的情况。此外,卫生保健员可能是从结核病发病率高的国家招募到澳大利亚的。这些卫生保健员更有可能在到达之前感染结核病,并随后在澳大利亚的卫生机构工作期间发展为活动性疾病。2001年,澳大利亚卫生保健中心共有20宗结核病呈报个案,其中10宗是在海外出生,而在2013年,77宗呈报个案中有70宗(91%)是在海外出生。1,2管理卫生保健中心的结核病风险是多方面的。需要将工作人员教育、意识、早期诊断、适当使用个人防护装备、环境控制和筛查程序相结合,以最大限度地减少向卫生保健工作者传播的风险以及从卫生保健工作者向患者传播的风险。在儿童和免疫功能低下者等较为脆弱的患者中,预防卫生保健工作者的院内传播尤为重要。本文件旨在描述被认为对澳大利亚所有医疗机构至关重要的组成部分,以尽量减少这种风险。它不打算用于操作,应参考具体的州和地区结核病控制规划政策。每个设施应根据这一管辖政策和决定风险的设施具体因素制定自己的卫生保健工作人员结核病风险管理政策,但至少应包括以下内容。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Communicable Diseases Intelligence
Communicable Diseases Intelligence INFECTIOUS DISEASES-
自引率
16.00%
发文量
0
期刊最新文献
Professor Mary-Louise McLaws (17 March 1953 – 12 August 2023) Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2016-2018 Final Report - Erratum to Commun Dis Intell (2018) 2022;46. (https://doi.org/10.33321/cdi.2022.46.28) COVID-19 Australia: Epidemiology Report 73 Reporting period ending 9 April 2023 Australian Rotavirus Surveillance Program: Annual Report, 2017 Invasive Pneumococcal Disease Surveillance, 1 January to 31 March 2017.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1